One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Continuity of treatment in ALS: Benefits and challenges of maintaining riluzole over the course of the disease
doi : 10.1016/j.jns.2024.123038
Volume 461, 15 June 2024, 123038
Cerebral cavernous malformations – An overview on genetics, clinical aspects and therapeutic strategies
Adriana Octaviana Dulamea, Ioan Cristian Lupescu
doi : 10.1016/j.jns.2024.123044
Volume 461, 15 June 2024, 123044
Glial and glioneuronal tumors: Navigating the complexity of evolving concepts and new classification
Peng Cheng Han a, Tiffany G. Baker b
doi : 10.1016/j.jns.2024.123058
Volume 461, 15 June 2024, 123058
Effect of lipid-lowering therapy on carotid plaque burden in older adults
Stella Iankov a, Aditya Sikand a, Joy Chowdhury a, J. David Spence a b c, Shahram Arsang Jang d, Seyed Mojtaba Sohrevardi a e, Daniel G. Hackam e, M. Reza Azarpazhooh a b f
doi : 10.1016/j.jns.2024.123023
Volume 461, 15 June 2024, 123023
Orthostatic hypotension, cognition and structural brain imaging in hemodynamically impaired patients
Naomi L.P. Starmans a, Frank J. Wolters b c, Anna E. Leeuwis d, Esther E. Bron c, Jeroen de Bresser e, Hans-Peter Brunner-La Rocca f, Julie Staals g, Majon Muller h, Geert Jan Biessels a, L. Jaap Kappelle a, on behalf of the Heart-Brain Connection Consortium
doi : 10.1016/j.jns.2024.123026
Volume 461, 15 June 2024, 123026
The link between insurance and blood pressure control in U.S. stroke survivors
Daniel M. Oh a 1, Michael McManus b 1, Daniela Markovic c, Bruce Ovbiagele d, Nerses Sanossian e f, Amytis Towfighi e f
doi : 10.1016/j.jns.2024.123043
Volume 461, 15 June 2024, 123043
Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative diseases
Ritu R. Trivedi a, Angela S. Archambault a, Clarice Pavlak a, Matteo Gastaldi b, Claudia Cantoni a, Laura Ghezzi a 1, Anne H. Cross a, Timothy M. Miller a, Gregory F. Wu a c d
doi : 10.1016/j.jns.2024.123041
Volume 461, 15 June 2024, 123041
Circulating cell-free DNA as a biomarker for molecular diagnosis of Neurocysticercosis
Yashvi Mehta a, Upninder Kaur a, Ritu Shree b, Manish Modi b, Vivek Lal b, Rakesh Sehgal c
doi : 10.1016/j.jns.2024.123039
Volume 461, 15 June 2024, 123039
Predicting hematoma expansion using machine learning: An exploratory analysis of the ATACH 2 trial
Arooshi Kumar a, Jens Witsch b, Jennifer Frontera c, Adnan I. Qureshi d, Eric Oermann c, Shadi Yaghi e, Kara R. Melmed c f
doi : 10.1016/j.jns.2024.123048
Volume 461, 15 June 2024, 123048
Typical and atypical MRI abnormalities in Wernicke's encephalopathy: Correlation with blood vitamin B1 levels
Akiyuki Hiraga a, Kazuho Kojima a, Satoshi Kuwabara b
doi : 10.1016/j.jns.2024.123045
Volume 461, 15 June 2024, 123045
Acetylcholinesterase inhibitors are ineffective in MuSK-antibody positive myasthenia gravis: Results of a study on 202 patients
R. Ricciardi a c, E. Latini a, M. Guida a, I. Koneczny b, M. Lucchi c, M. Maestri a, A. De Rosa a, A. Vincent d
doi : 10.1016/j.jns.2024.123047
Volume 461, 15 June 2024, 123047
Apheresis treatment in autoimmune neurological diseases: Predictors of good clinical outcome and success of follow-up therapy with B-cell depletion
Mathias Fousse a, Klaus Fassbender a, Stefan J. Schunk b, Tina Schmidt c, Jakob Stögbauer a
doi : 10.1016/j.jns.2024.123050
Volume 461, 15 June 2024, 123050
Characterization of clinical serum cardiac biomarker levels in individuals with Friedreich ataxia
David R. Lynch a b, Sonal Sharma a, Patrick Hearle a, Nathaniel Greeley a, Katherine Gunther a, Medina Keita a, Cassandra Strawser a, Lauren Hauser a, Courtney Park a, Kimberly Schadt a, Kimberly Y. Lin b c
doi : 10.1016/j.jns.2024.123053
Volume 461, 15 June 2024, 123053
Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification
Charalampos Skarlis a, Vassilis Papadopoulos b, Sylvia Raftopoulou a, Clio P. Mavragani a c 1, Maria-Eleftheria Evangelopoulos b 1
doi : 10.1016/j.jns.2024.123046
Volume 461, 15 June 2024, 123046
Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation
Dejan Jakimovski a, Ferhan Qureshi b, Murali Ramanathan c, Kian Jalaleddini b, Ati Ghoreyshi b, Michael G. Dwyer a, Niels Bergsland a, Bianca Weinstock-Guttman d, Robert Zivadinov a e
doi : 10.1016/j.jns.2024.123055
Volume 461, 15 June 2024, 123055
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Estimation of pathological lesion stage from brain images
Michiaki Kinoshita a, Kiyomitsu Oyanagi b, Akira Matsushima c d, Yasufumi Kondo c, Shigeki Hirano e, Keisuke Ishizawa f, Kenji Ishihara g, Seishi Terada h, Teruhiko Inoue i, Ikuru Yazawa j, Yukihiko Washimi k, Mitsunori Yamada b, Jun Nakayama l 1, Yoshio Mitsuyama i, Shu-ichi Ikeda c, Yoshiki Sekijima c
doi : 10.1016/j.jns.2024.123027
Volume 461, 15 June 2024, 123027
Enlarged perivascular spaces and their association with motor, cognition, MRI markers and cerebrovascular risk factors in male fragile X premutation carriers
Andrea Elias-Mas a b c, Jun Yi Wang d, Laia RodrÃguez-Revenga e f g, Kyoungmi Kim h, Flora Tassone i j, David Hessl i k, Susan M. Rivera d i l, Randi Hagerman i m
doi : 10.1016/j.jns.2024.123056
Volume 461, 15 June 2024, 123056
Focal compression of the cervical spinal cord alone does not indicate high risk of neurological deterioration in patients with a diagnosis of mild degenerative cervical myelopathy
Abdul Al-Shawwa a, Mike Craig b, Kalum Ost a, David Anderson d, W. Bradley Jacobs b e, Nathan Evaniew b c, Saswati Tripathy b, Jacques Bouchard b c, Steve Casha b e, Roger Cho b c, Stephen du Plessis b e, Peter Lewkonia b c, Fred Nicholls b c, Paul T. Salo b c, Alex Soroceanu b c, Ganesh Swamy b c, Kenneth C. Thomas b c, Michael M.H. Yang b e, David W. Cadotte a b d e
doi : 10.1016/j.jns.2024.123042
Volume 461, 15 June 2024, 123042
Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study
Noriko Nishikawa a, Taku Hatano a, Kenya Nishioka b, Shin-Ichi Ueno a, Shinji Saiki a, Ryota Nakamura c, Asako Yoritaka d, Takashi Ogawa c, Yasushi Shimo e, Wataru Sako a, Hideki Shimura b, Yoshiaki Furukawa b, Takanori Kamei f, Takayuki Ishida f, Nobutaka Hattori a, on behalf of the J-SILVER study group
doi : 10.1016/j.jns.2024.123051
Volume 461, 15 June 2024, 123051
The periprocedural respiratory safety of propofol sedation in patients with a motor neuron disease undergoing percutaneous endoscopic gastrostomy insertion
Giel J.L. van Neerven a, Willem-Jan Schelling b, Katrien van den Borne c, Kim Bijleveld b, Arlinda Baars a, Hajo Flink a, Lennard P.L. Gilissen a
doi : 10.1016/j.jns.2024.123049
Volume 461, 15 June 2024, 123049
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry
Maria A. Piedrabuena a, Jorge Correale a al, Marcela Fiol a, Mariano Marrodan a, Juan I. Rojas b, Marina Alonso c, AgustÃn Pappolla d, Jimena Miguez d, Liliana Patrucco d, Edgardo Cristiano e, Carlos Vrech f, Leila Cohen g, Ricardo Alonso h, Berenice Silva i, Geraldine Luetic j, Norma Deri k, Marcos Burgos l, Susana Liwacki m, Raul Piedrabuena n, Verónica Tkachuk o…MarÃa C. Ysrraelit a
doi : 10.1016/j.jns.2024.123052
Volume 461, 15 June 2024, 123052
Reduced sensitivity to future consequences underlies gambling decision in cerebellar ataxia
Ruo-Yah Lai a b, Eli Levy a b, Christian J. Amlang a b, Ihika Rampalli c, Rory Mahabir c, Ming-Kai Pan d e f g, Chi-Ying R. Lin c, Sheng-Han Kuo a b
doi : 10.1016/j.jns.2024.123060
Volume 461, 15 June 2024, 123060
Neurophysiological and brain structural insights into cyclin-dependent kinase-like 5 deficiency disorder: Visual and auditory evoked potentials and MRI analysis
Ryo Takeguchi a, Yuichi Akaba a, Mami Kuroda a, Ryosuke Tanaka a, Teruyuki Tanaka b, Masayuki Itoh c, Satoru Takahashi a
doi : 10.1016/j.jns.2024.123063
Volume 461, 15 June 2024, 123063
Sex differences in outcomes of carotid artery stenting
Kazutaka Uchida a, Manabu Shirakawa a, Fumihiro Sakakibara a, Nobuyuki Sakai b, Koji Iihara c, Hirotoshi Imamura c, Akira Ishii d, Yuji Matsumaru e, Chiaki Sakai f, Tetsu Satow g, Shinichi Yoshimura a, The JR-NET4 Study Group
doi : 10.1016/j.jns.2024.123062
Volume 461, 15 June 2024, 123062
Comments on energy conservation treatments for MS-related fatigue and a new proposal
Helmut Hildebrandt a b, Paul Eling c
doi : 10.1016/j.jns.2024.123040
Volume 461, 15 June 2024, 123040
Distinct retinal reflectance spectra from retinal hyperspectral imaging in Parkinson's disease
Emi Ueda a, Mitsuru Watanabe b, Daisuke Nakamura c, Dai Matsuse b, Eizo Tanaka b, Kohta Fujiwara a, Sawako Hashimoto a, Shun Nakamura a, Noriko Isobe b, Koh-Hei Sonoda a
doi : 10.1016/j.jns.2024.123061
Volume 461, 15 June 2024, 123061
Corrigendum to “Inhibition of mammalian target of rapamycin attenuates early brain injury through modulating microglial polarization after experimental subarachnoid hemorrhage in rats� [Journal of the Neurological Sciences (2016) 224–231]
Wanchun You a 1, Zhong Wang a 1, Haiying Li a, Haitao Shen a, Xiang Xu a, Genlai Jia b, Gang Chen a
doi : 10.1016/j.jns.2024.122977
Volume 461, 15 June 2024, 122977
